These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32943286)

  • 1. Molecular T-cell‒mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft loss.
    Halloran K; Parkes MD; Timofte I; Snell G; Westall G; Havlin J; Lischke R; Hachem R; Kreisel D; Levine D; Kubisa B; Piotrowska M; Juvet S; Keshavjee S; Jaksch P; Klepetko W; Hirji A; Weinkauf J; Halloran PF
    J Heart Lung Transplant; 2020 Dec; 39(12):1327-1337. PubMed ID: 32943286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular assessment of rejection and injury in lung transplant biopsies.
    Halloran KM; Parkes MD; Chang J; Timofte IL; Snell GI; Westall GP; Hachem R; Kreisel D; Trulock E; Roux A; Juvet S; Keshavjee S; Jaksch P; Klepetko W; Halloran PF
    J Heart Lung Transplant; 2019 May; 38(5):504-513. PubMed ID: 30773443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Responses in Histologic Versus Molecular Diagnoses of Lung Rejection.
    Zajacova A; Mackova M; Halloran K; Gauthier P; Balko J; Guney M; Rakita D; Svorcova M; Kolarik J; Vachtenheim J; Pozniak J; Simonek J; Fila L; Lischke R; Halloran PF; Havlin J
    Transpl Int; 2024; 37():12847. PubMed ID: 39131792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular phenotyping of rejection-related changes in mucosal biopsies from lung transplants.
    Halloran K; Parkes MD; Timofte IL; Snell GI; Westall GP; Hachem R; Kreisel D; Levine D; Juvet S; Keshavjee S; Jaksch P; Klepetko W; Hirji A; Weinkauf J; Halloran PF
    Am J Transplant; 2020 Apr; 20(4):954-966. PubMed ID: 31679176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining a natural killer cell-enriched molecular rejection-like state in lung transplant transbronchial biopsies.
    Gauthier PT; Mackova M; Hirji A; Weinkauf J; Timofte IL; Snell GI; Westall GP; Havlin J; Lischke R; Zajacová A; Simonek J; Hachem R; Kreisel D; Levine D; Kubisa B; Piotrowska M; Juvet S; Keshavjee S; Jaksch P; Klepetko W; Halloran K; Halloran PF
    Am J Transplant; 2023 Dec; 23(12):1922-1938. PubMed ID: 37295720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of chronic lung transplant rejection by transbronchial biopsy.
    Cagle PT; Brown RW; Frost A; Kellar C; Yousem SA
    Mod Pathol; 1995 Feb; 8(2):137-42. PubMed ID: 7777473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building a tissue-based molecular diagnostic system in heart transplant rejection: The heart Molecular Microscope Diagnostic (MMDx) System.
    Halloran PF; Potena L; Van Huyen JD; Bruneval P; Leone O; Kim DH; Jouven X; Reeve J; Loupy A
    J Heart Lung Transplant; 2017 Nov; 36(11):1192-1200. PubMed ID: 28662985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of the value of transbronchial lung biopsy after lung transplantation.
    Boehler A; Vogt P; Zollinger A; Weder W; Speich R
    Eur Respir J; 1996 Apr; 9(4):658-62. PubMed ID: 8726927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
    Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance transbronchial biopsy in the diagnosis of acute lung rejection in heart and lung and lung transplant recipients.
    Vitulo P; Cremaschi P; Arbustini E; Volpato G; Volpini E; Martinelli L; Fracchia C; Rossi A
    Monaldi Arch Chest Dis; 1996 Feb; 51(1):12-5. PubMed ID: 8901314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study.
    Halloran PF; Pereira AB; Chang J; Matas A; Picton M; De Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    Am J Transplant; 2013 Sep; 13(9):2352-63. PubMed ID: 23915426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C4d detection and histological patterns in the diagnosis of antibody-mediated rejection after lung transplantation: a single-centre study.
    Ngo C; Danel C; Duong-Quy S; Dauriat G; Castier Y; Lortat-Jacob B; Mal H; Brugière O; Cazes A
    Histopathology; 2019 Jun; 74(7):988-996. PubMed ID: 30636056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular features of chronic lung allograft dysfunction in lung transplant airway mucosa.
    Halloran K; Mackova M; Parkes MD; Hirji A; Weinkauf J; Timofte IL; Snell GI; Westall GP; Lischke R; Zajacova A; Havlin J; Hachem R; Kreisel D; Levine D; Kubisa B; Piotrowska M; Juvet S; Keshavjee S; Jaksch P; Klepetko W; Halloran PF
    J Heart Lung Transplant; 2022 Dec; 41(12):1689-1699. PubMed ID: 36163162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
    Cherukuri A; Mehta R; Sharma A; Sood P; Zeevi A; Tevar AD; Rothstein DM; Hariharan S
    Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of T lymphocytes in posttransplant transbronchial biopsies.
    Tavora F; Drachenberg C; Iacono A; Burke AP
    Hum Pathol; 2009 Apr; 40(4):505-15. PubMed ID: 19121842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients.
    Hopkins PM; Aboyoun CL; Chhajed PN; Malouf MA; Plit ML; Rainer SP; Glanville AR
    J Heart Lung Transplant; 2002 Oct; 21(10):1062-7. PubMed ID: 12398870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival.
    Halloran PF; Madill-Thomsen K; Aliabadi-Zuckermann AZ; Cadeiras M; Crespo-Leiro MG; Depasquale EC; Deng M; Gökler J; Hall S; Jamil A; Kim DH; Kobashigawa J; Macdonald P; Melenovsky V; Patel J; Potena L; Shah K; Stehlik J; Zuckermann A
    Am J Transplant; 2024 Aug; 24(8):1414-1426. PubMed ID: 38527588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular phenotype of kidney transplant indication biopsies with inflammation in scarred areas.
    Halloran PF; Matas A; Kasiske BL; Madill-Thomsen KS; Mackova M; Famulski KS
    Am J Transplant; 2019 May; 19(5):1356-1370. PubMed ID: 30417539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of T-cell-mediated kidney rejection in formalin-fixed, paraffin-embedded tissues using RNA-Seq-based machine learning algorithms.
    Liu P; Tseng G; Wang Z; Huang Y; Randhawa P
    Hum Pathol; 2019 Feb; 84():283-290. PubMed ID: 30296518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.